Plasma citrulline is a biomarker of enterocyte mass and an indicator of parenteral nutrition in HIV-infected patients

American Journal of Clinical Nutrition

Volumn 90, Issue 3, 2009, Pages 587-594

  Crenn, Pascal ^a,b   De Truchis, Pierre ^a   Neveux, Nathalie ^b,c   Galpérine, Tatiana ^a   Cynober, Luc ^b,c   Melchior, Jean Claude ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIRETROVIRUS AGENT; ARGININE; C REACTIVE PROTEIN; CD4 ANTIGEN; CITRULLINE; PROTEINASE INHIBITOR; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC DIARRHEA; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DIARRHEA; DISEASE MARKER; ENTEROPATHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE CELL; INTESTINE INFECTION; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUTRITIONAL STATUS; OPPORTUNISTIC INFECTION; PANCREAS DISEASE; PARENTERAL NUTRITION; PROSPECTIVE STUDY; VIRUS DETECTION; VIRUS LOAD; AIDS RELATED COMPLEX; BLOOD; METABOLISM; MIDDLE AGED; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CITRULLINE; DIARRHEA; ENTEROCYTES; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; SERUM ALBUMIN;

EID: 70349581233     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.27448     Document Type: Article

References (36)

1. Monkemuller KE, Call SA, Lazenby AJ, Wilcox CM. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol 2000;95:457-462
2. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17-26. (Pubitemid 32619279)
3. Monkemuller KE, Lazenby AJ, Lee DH, Loudon R, Wilcox CM. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci 2005;50:230-234 (Pubitemid 40311525)
4. Campa A, Yang Z, Lai S, et al. HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;41:1179-1185 (Pubitemid 41429483)
5. Wilcox CM, Saag MS. Gastrointestinal complications of HIV infection: changing priorities in the HAART era. Gut 2008;57:861-870
6. Kotler DP, Orenstein JM. Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation. Am J Gastroenterol 1994;89:1998-2002.
7. Batman PA, Kapembwa MS, Miller AR, et al. HIV enteropathy: comparative morphometry of the jejunal mucosa of HIV infected patients resident in the United Kingdom and Uganda. Gut 1998;43:350-355
8. Guest JL, Ruffin C, Tschampa JM, DeSilva KE, Rimland D. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Pharmacotherapy 2004;24: 727-735 (Pubitemid 38747857)
9. Curis E, Crenn P, Cynober L. Citrulline and the gut. Curr Opin Clin Nutr Metab Care 2007;10:620-626
10. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008;27:328-339
11. van de Poll MC, Siroen MP, van Leeuwen PA, et al. Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am J Clin Nutr 2007;85:167-172
12. Wu G, Knabe DA, Flynn NE. Synthesis of citrulline from glutamine in pig enterocytes. Biochem J 1994;299:115-121 (Pubitemid 24106297)
13. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000;119:1496-1505 (Pubitemid 32198675)
14. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003;124: 1210-1219 (Pubitemid 36531797)
15. Papadia C, Sherwood RA, Kalantzis C, et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol 2007;102: 1474-1482 (Pubitemid 46976295)
16. Lutgens LC, Deutz N, Granzier-Peeters M, et al. Plasma citrulline concentration: a surrogate end point for radiation-induced mucosal atrophy of the small bowel: a feasibility study in 23 patients. Int J Radiat Oncol Biol Phys 2004;60:275-285 (Pubitemid 39165495)
17. Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline and rejection in small bowel transplantation: a preliminary report. Transplantation 2001;72:1212-1216 (Pubitemid 33026597)
18. Gondolesi G, Ghirardo S, Raymond K, et al. The value of plasma citrulline to predict mucosal injury in intestinal allografts. Am J Transplant 2006;6:2786-2790 (Pubitemid 44571701)
19. van de Poll MC, Soeters PB, Deutz NE, Fearon KC, Dejong CH. Renal metabolism of amino acids: its role in interorgan amino acid exchange. Am J Clin Nutr 2004;79:185-197
20. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. Gastroenterology 1992;102:330-354
21. Batman PA, Kotler DP, Kapembwa MS, et al. HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia- infected jejunal mucosa. AIDS 2007;21:433-439
22. Peters JH, Wierdsma NJ, Teerlink T, van Leeuwen PA, Mulder CJ, van Bodegraven AA. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity. Am J Gastroenterol 2007;102:2814-2819 (Pubitemid 350179333)
23. Schon T, Elias D, Moges F, et al. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur Respir J 2003;21:483-488 (Pubitemid 36336209)
24. Reka S, Kotler DP. Correlation of intestinal structure and function in HIV infection. Gastrointest Endosc Clin N Am 1998;8:841-856 (Pubitemid 28495182)
25. Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008;300:555-570
26. American Gastroenterological Association. American Gastroenterological Association medical position statement: guidelines for the management of malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996;111:1722-1723
27. Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987;11: 8-13.
28. Ockenga J, Grimble R, Jonkers-Schuitema C, et al. ESPEN guidelines on enteral nutrition: wasting in HIV and other chronic infectious diseases. Clin Nutr 2006;25:319-329 (Pubitemid 43832526)
29. Crenn P, Rakotoanbinina B, Raynaud JJ, Thuillier F, Messing B, Melchior JC. Hyperphagia contributes to the normal body composition and protein-energy balance in HIV-infected asymptomatic men. J Nutr 2004;134:2301-2306 (Pubitemid 39201600)
30. Melchior JC, Gelas P, Carbonnel F, et al. Improved survival by home total parenteral nutrition in AIDS patients: follow-up of a controlled randomized prospective trial. AIDS 1998;12:336-337 (Pubitemid 28045473)
31. Yarasheski KE, Zachwieja JJ, Gischler J, Crowley J, Horgan MM, Powderly WG. Increased plasma gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting. Am J Physiol 1998; 275:E577-83. (Pubitemid 128732045)
32. Gaginella TS, Chadwick VS, Debongnie JC, Lewis JC, Phillips SF. Perfusion of rabbit colon with ricinoleic acid: dose-related mucosal injury, fluid secretion, and increased permeability. Gastroenterology 1977;73:95-101.
33. Blijlevens NM, Lutgens LC, Schattenberg AV, Donnelly JP. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 2004;34: 193-196
34. Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer 2005;103:191-199 (Pubitemid 39665473)
35. Bailly-Botuha C, Colomb V, Thioulouse E, et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res (Epub ahead of print 24 December 2008).
36. Herbers AH, Blijlevens NM, Donnelly JP, de Witte TJ. Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. Bone Marrow Transplant 2008;42:345-349